.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Mallinckrodt
US Department of Justice
Express Scripts
Boehringer Ingelheim
Cerilliant
Cantor Fitzgerald
Julphar
Chubb
Covington

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,273,876

« Back to Dashboard

Which drugs does patent 8,273,876 protect, and when does it expire?


Patent 8,273,876 protects LEVITRA and is included in one NDA. There have been three Paragraph IV challenges on Levitra.

This patent has forty-six patent family members in thirty-one countries.

Summary for Patent: 8,273,876

Title:Medicaments containing vardenafil hydrochloride trihydrate
Abstract: The invention relates to a method for producing medicaments that contain vardenafil hydrochloride, essentially as trihydrate in solid form, and to medicaments that can be obtained according to this method.
Inventor(s): Serno; Peter (Gladbach, DE), Grunenberg; Alfons (Dormagen, DE), Ohm; Andreas (Neuss, DE), Bellinghausen; Rainer (Odenthal, DE), Vollers; Eimer (Leverkusen, DE), Henck; Jan-Olav (Leverkusen, DE)
Assignee: Bayer Intellectual Property GmbH (Monheim, DE)
Application Number:10/521,534
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Bayer HlthcareLEVITRAvardenafil hydrochlorideTABLET;ORAL021400-003Aug 19, 2003ABRXYesNo► Subscribe► Subscribe► SubscribeTREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET
Bayer HlthcareLEVITRAvardenafil hydrochlorideTABLET;ORAL021400-001Aug 19, 2003ABRXYesNo► Subscribe► Subscribe► SubscribeTREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET
Bayer HlthcareLEVITRAvardenafil hydrochlorideTABLET;ORAL021400-002Aug 19, 2003ABRXYesNo► Subscribe► Subscribe► SubscribeTREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET
Bayer HlthcareLEVITRAvardenafil hydrochlorideTABLET;ORAL021400-004Aug 19, 2003ABRXYesYes► Subscribe► Subscribe► SubscribeTREATEMENT OF ERECTIILE DYSFUNCTION BY ADMINISTERING A FILM-COATED TABLET
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,273,876

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany102 32 113Jul 16, 2002
PCT Information
PCT FiledJuly 03, 2003PCT Application Number:PCT/EP03/07093
PCT Publication Date:January 22, 2004PCT Publication Number: WO2004/006894

Non-Orange Book Patents for Patent: 8,273,876

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,841,446Medicaments containing vardenafil hydrochloride trihydrate► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,273,876

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark2272505► Subscribe
China102210689► Subscribe
Cuba23473► Subscribe
Cyprus1112460► Subscribe
Cyprus1118394► Subscribe
Germany10232113► Subscribe
Denmark1523303► Subscribe
EcuadorSP055541► Subscribe
European Patent Office1523303► Subscribe
European Patent Office2272505► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Chinese Patent Office
Novartis
Teva
McKesson
Cantor Fitzgerald
UBS
Fuji
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot